SEARCH RESULT

Total Matching Records found : 1152

PM should head food security bill: MS Swaminathan- Jyotika Sood

Giving right to food is not enough to deliver food, say speakers at a conference on food security Agriculture scientist M S Swaminathan has called for setting up a body headed by the prime minister for effective execution of the National Food Security Bill (NFSB) once it is enacted. All chief ministers should be members of this board, he added. NFSB was cleared by the Union Cabinet and introduced in Parliament in...

More »

Wheat glut: farms face falling prices, rising costs-Ruchira Singh

-Live Mint After a record harvest of 90.23 mt this year, the govt’s wheat stocks were at 38.2 mt as of 1 May Worry lines run deep on the faces of wheat farmers in Sehrala in Haryana as falling prices, higher input costs and poor infrastructure erode earnings and cast doubt over not just their next crop, but their future in agriculture as well. Agents in the grain market of Ballabgarh said spot...

More »

Export surplus wheat, says panel-Nitin Sethi

A panel headed by the PM's chief economic advisor C Rangarajan has recommended exporting 2 million tonnes (mt) of wheat at a subsidy of Rs 1,500 crore through government channels and another 1 mt through private traders at a subsidy of Rs 150 crore. Warning that just Exports would not be enough to manage the overflowing godowns and could cause political problems, the panel has also recommended distribution of 8 mt...

More »

And not a grain to eat-Brinda Karat

What stops the government from using good harvests to reduce, if not eliminate, hunger? For ordinary folk, a 3 per cent increase in food grain production over that of last year, combined with strong procurement operations and good buffer stocks of rice and wheat would be a cause for some celebration. It would be seen as an opportunity to tackle the widespread food insecurity that exists in India today. Instead, we...

More »

Protests in US over high pricing of Novartis' anti-cancer drug Glivec-Divya Rajagopal

Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous, multi-billion dollar anti-cancer drug Glivec, a development which challenges pharma MNCs' claims of cheap access and affordability for patented drugs. Such protests, which began first in Europe, and have now spread to the US, could make it more difficult for pharma MNCs in developing countries to convince sceptical governments...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close